Page last updated: 2024-08-25

broxaterol and (9R)-9-chloro-11,17-dihydroxy-17-(2-hydroxy-1-oxoethyl)-10,13,16-trimethyl-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one

broxaterol has been researched along with (9R)-9-chloro-11,17-dihydroxy-17-(2-hydroxy-1-oxoethyl)-10,13,16-trimethyl-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Ganassini, A; Rossi, A	1

Trials

1 trial(s) available for broxaterol and (9R)-9-chloro-11,17-dihydroxy-17-(2-hydroxy-1-oxoethyl)-10,13,16-trimethyl-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one

Article	Year
Short-term regular beta 2-adrenergic agonists treatment is safe in mild asthmatics taking low doses of inhaled steroids. The Journal of asthma : official journal of the Association for the Care of Asthma, 1997, Volume: 34, Issue:1 Topics: Administration, Inhalation; Adrenergic beta-Antagonists; Adult; Asthma; Beclomethasone; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Isoxazoles; Male; Middle Aged; Respiratory Mechanics; Vital Capacity	1997

Article

Year

Short-term regular beta 2-adrenergic agonists treatment is safe in mild asthmatics taking low doses of inhaled steroids.

The Journal of asthma : official journal of the Association for the Care of Asthma, 1997, Volume: 34, Issue:1

Topics: Administration, Inhalation; Adrenergic beta-Antagonists; Adult; Asthma; Beclomethasone; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Isoxazoles; Male; Middle Aged; Respiratory Mechanics; Vital Capacity

1997